The FDA has granted accelerated approval to zenocutuzumab, a new drug for adults with advanced non-small-cell lung cancer ...
Aquestive Therapeutics (AQST) announced receipt of positive feedback from the U.S. Food and Drug Administration prior to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback